Published in J Ethnopharmacol on April 18, 2006
α-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacogn Rev (2011) 1.55
Silencing quorum sensing through extracts of Melicope lunu-ankenda. Sensors (Basel) (2012) 1.22
Phytotherapy in diabetes: Review on potential mechanistic perspectives. World J Diabetes (2014) 1.14
Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes (2013) 1.09
Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia. BMC Complement Altern Med (2012) 1.08
In vitro study on α-amylase inhibitory activity of an Indian medicinal plant, Phyllanthus amarus. Indian J Pharmacol (2010) 1.06
Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evid Based Complement Alternat Med (2010) 1.06
In vivo Studies on Antidiabetic Plants Used in South African Herbal Medicine. J Clin Biochem Nutr (2010) 1.01
A pharmacological appraisal of medicinal plants with antidiabetic potential. J Pharm Bioallied Sci (2012) 0.91
In vitro α-amylase inhibitory activity and in vivo hypoglycemic effect of methanol extract of Citrus macroptera Montr. fruit. Asian Pac J Trop Biomed (2014) 0.89
Anti-quorum sensing activity of the traditional Chinese herb, Phyllanthus amarus. Sensors (Basel) (2013) 0.88
Evaluation of the inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes. BMC Complement Altern Med (2013) 0.88
Modes of inhibition of α -amylase and α -glucosidase by aqueous extract of Morinda lucida Benth leaf. Biomed Res Int (2013) 0.84
Bioactivity-Guided Separation of an α-Amylase Inhibitor Flavonoid from Salvia virgata. Iran J Pharm Res (2013) 0.83
Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri. Interdiscip Toxicol (2011) 0.83
Evaluation of antiviral activities of four local Malaysian Phyllanthus species against herpes simplex viruses and possible antiviral target. Int J Med Sci (2013) 0.80
Antihyperglycemic Potential of Grewia asiatica Fruit Extract against Streptozotocin-Induced Hyperglycemia in Rats: Anti-Inflammatory and Antioxidant Mechanisms. Oxid Med Cell Longev (2015) 0.80
An overview of important ethnomedicinal herbs of Phyllanthus species: present status and future prospects. ScientificWorldJournal (2014) 0.80
The role of triterpenes in the management of diabetes mellitus and its complications. Phytochem Rev (2014) 0.79
Novel nutraceutic therapies for the treatment of metabolic syndrome. World J Diabetes (2016) 0.79
Carbohydrase inhibition and anti-cancerous and free radical scavenging properties along with DNA and protein protection ability of methanolic root extracts of Rumex crispus. Nutr Res Pract (2012) 0.79
Effect of Butea monosperma Lam. leaves and bark extracts on blood glucose in streptozotocin-induced severely diabetic rats. Pharmacognosy Res (2012) 0.78
Antidiabetic activity of Pterospermum acerifolium flowers and glucose uptake potential of bioactive fraction in L6 muscle cell lines with its HPLC fingerprint. Biomed Res Int (2014) 0.78
In vitro hypoglycemic effects of Butea monosperma Lam. leaves and bark. J Food Sci Technol (2011) 0.78
The globalization of traditional medicine in northern peru: from shamanism to molecules. Evid Based Complement Alternat Med (2013) 0.78
Sequencing, De novo Assembly, Functional Annotation and Analysis of Phyllanthus amarus Leaf Transcriptome Using the Illumina Platform. Front Plant Sci (2016) 0.77
[Ethnobotanical study of plants used in the treatment of diabetes in the traditional medicine of Maritime Region, Togo]. Pan Afr Med J (2015) 0.77
Preliminary in vitro and in vivo evaluation of antidiabetic activity of Ducrosia anethifolia Boiss. and its linear furanocoumarins. Biomed Res Int (2014) 0.77
Bioactive compounds from Carissa opaca roots and xanthine oxidase and alpha-amylase inhibitory activities of their methanolic extract and its fractions in different solvents. Pharmacognosy Res (2015) 0.77
Synthesis and Evaluation of Novel Triterpene Analogues of Ursolic Acid as Potential Antidiabetic Agent. PLoS One (2015) 0.76
The inhibitory activity of herbal medicines on the keys enzymes and steps related to carbohydrate and lipid digestion. BMC Complement Altern Med (2016) 0.75
Capillary electrophoresis as a screening tool for alpha amylase inhibitors in plant extracts. Saudi Pharm J (2010) 0.75
Enzyme Assay Guided Isolation of an α-Amylase Inhibitor Flavonoid from Vaccinium arctostaphylos Leaves. Iran J Pharm Res (2011) 0.75
Enzyme inhibitory and radical scavenging effects of some antidiabetic plants of Turkey. Iran J Basic Med Sci (2014) 0.75
Parkia speciosa Hassk.: A Potential Phytomedicine. Evid Based Complement Alternat Med (2013) 0.75
In-vitro Studies on Calotropis procera Leaf Extracts as Inhibitors of Key Enzymes Linked to Diabetes Mellitus. Iran J Pharm Res (2016) 0.75
Averrhoa bilimbi Linn.: A review of its ethnomedicinal uses, phytochemistry, and pharmacology. J Pharm Bioallied Sci (2017) 0.75
Expression of liver alpha-amylase in obese mouse hepatocytes. Gastroenterol Hepatol Bed Bench (2016) 0.75
Anti-hyperglycaemic and antioxidant effects of Bidens tripartita and quantitative analysis on its active principles. Iran J Basic Med Sci (2016) 0.75
An in vitro and in vivo study of the α-amylase activity of phaseolamin. J Med Food (2014) 0.75
Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B. Sci Rep (2016) 0.75
Hypoglycemic Effect of Sargassum ringgoldianum Extract in STZ-induced Diabetic Mice. Prev Nutr Food Sci (2012) 0.75
Effect of boiling on the antidiabetic property of enzyme treated sheep milk casein. Vet World (2016) 0.75
Antidiabetic activity of the ethyl acetate fraction of Ficus lutea (Moraceae) leaf extract: comparison of an in vitro assay with an in vivo obese mouse model. BMC Complement Altern Med (2016) 0.75
Corchorus Olitorius Linn: A Rich Source of Ω3-Fatty Acids. Pharm Anal Acta (2016) 0.75
Medicinal plants with potential anti-arthritic activity. J Intercult Ethnopharmacol (2015) 0.75
In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complement Altern Med (2016) 0.75
Ocimum basilicum extract exhibits antidiabetic effects via inhibition of hepatic glucose mobilization and carbohydrate metabolizing enzymes. J Intercult Ethnopharmacol (2017) 0.75
ANTIOXIDANT ACTIVITY AND A-AMYLASE INHIBITORY POTENTIAL OF ROSA CANINA L. Afr J Tradit Complement Altern Med (2017) 0.75
In vitro biological assessment of Homalium zeylanicum and isolation of lucidenic acid A triterpenoid. Toxicol Rep (2017) 0.75
Fatty Acid Profiling and In Vitro Antihyperglycemic Effect of Leucas cephalotes (Roth) Spreng via Carbohydrate Hydrolyzing Enzyme Inhibition. Pharmacogn Mag (2017) 0.75
Evaluation of seed extracts from plants found in the Caatinga biome for the control of Aedes aegypti. Parasitol Res (2014) 0.75
Oleanolic acid and ursolic acid as potential inhibitors of human salivary α-amylase: insights from in vitro assays and in silico simulations. J Mol Model (2017) 0.75
Antidiabetic and antioxidant functionality associated with phenolic constituents from fruit parts of indigenous black jamun (Syzygium cumini L.) landraces. J Food Sci Technol (2017) 0.75
Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science (1997) 7.07
mTOR and cancer therapy. Oncogene (2006) 3.07
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ (1990) 2.24
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation. J Biol Chem (1999) 2.08
Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors. Mol Cell Biol (2001) 2.03
Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development. Eur J Cancer (2004) 1.92
Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res (1999) 1.89
Amplification of the gli gene in childhood sarcomas. Cancer Res (1989) 1.84
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. J Natl Cancer Inst (1998) 1.82
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. Cancer Res (1994) 1.75
Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition. Clin Cancer Res (2001) 1.65
A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet (1987) 1.60
Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts. Clin Cancer Res (2001) 1.56
Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am J Pathol (1994) 1.55
Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Clin Cancer Res (1999) 1.47
Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res (1992) 1.43
Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol (1999) 1.41
Studies on the mechanism of resistance to rapamycin in human cancer cells. Mol Pharmacol (1998) 1.41
Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. Clin Cancer Res (2000) 1.35
Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol (1990) 1.34
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Anti-inflammatory activities of the methanol extracts and an isolated furanoditerpene constituent of Sphenocentrum jollyanum Pierre (Menispermaceae). J Ethnopharmacol (2005) 1.29
Mechanisms of resistance to rapamycins. Drug Resist Updat (2001) 1.28
In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol (2000) 1.28
p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin. Cancer Res (2001) 1.26
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol (1997) 1.25
P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol (2000) 1.22
Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine. Cancer Res (1979) 1.21
Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest (1994) 1.19
Predicted mechanisms of resistance to mTOR inhibitors. Br J Cancer (2006) 1.17
Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res (1987) 1.17
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft. Clin Cancer Res (2000) 1.16
Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity. Phytomedicine (2004) 1.15
An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11. Cancer Gene Ther (2008) 1.15
An evaluation of the activity related to inflammation of four plants used in Thailand to treat arthritis. J Ethnopharmacol (2003) 1.14
Effects of cytotoxic agents on TdR incorporation and growth delay in human colonic tumour xenografts. Br J Cancer (1977) 1.12
Tyrosinase inhibition by extracts and constituents of Sideroxylon inerme L. stem bark, used in South Africa for skin lightening. J Ethnopharmacol (2008) 1.11
Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Cancer Res (1981) 1.09
The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts. Eur J Cancer Clin Oncol (1982) 1.07
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol (2001) 1.07
Antimicrobial and antiinflammatory activities of extracts and constituents of Oroxylum indicum (L.) Vent. Phytomedicine (1998) 1.05
Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Clin Cancer Res (1999) 1.04
Efficacy of systemic administration of irinotecan against neuroblastoma xenografts. Clin Cancer Res (1997) 1.04
Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J Pharm Pharmacol (1999) 1.04
Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation. J Nat Prod (1999) 1.03
Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol (1995) 1.01
Ethnopharmacology of some Buddleja species. J Ethnopharmacol (1984) 1.01
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents. Cancer Chemother Pharmacol (1998) 1.00
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol (1994) 1.00
N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res (2000) 0.98
Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells. Oncogene (2007) 0.98
Growth and characterization of childhood rhabdomyosarcomas as xenografts. J Natl Cancer Inst (1982) 0.98
Malignant rhabdoid tumor: a highly malignant childhood tumor with minimal karyotypic changes. Genes Chromosomes Cancer (1990) 0.97
O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc Natl Acad Sci U S A (1985) 0.97
Clinical use of topoisomerase I inhibitors in anticancer treatment. Med Pediatr Oncol (2000) 0.96
P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma. J Clin Oncol (1996) 0.96
Activity of extracts and isolated naphthoquinones from Kigelia pinnata against Plasmodium falciparum. J Nat Prod (2000) 0.95
Antiplasmodial activity of extracts and alkaloids of three Alstonia species from Thailand. Planta Med (1999) 0.94
Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays. Clin Cancer Res (1998) 0.94
Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts. Biochem Pharmacol (1988) 0.94
Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke. Cancer (1999) 0.93
Evaluation of single-agent therapy in human colorectal tumour xenografts. Br J Cancer (1978) 0.93
Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots. Planta Med (2000) 0.93
Effects of Buddleja globosa leaf and its constituents relevant to wound healing. J Ethnopharmacol (2001) 0.93
Cytotoxic activity of indole alkaloids from Alstonia macrophylla. Planta Med (1999) 0.93
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism. Pharmacol Biochem Behav (2003) 0.91
Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene. Cancer Res (1996) 0.91
Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models. Clin Cancer Res (1998) 0.90
Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma. Clin Cancer Res (1996) 0.90
Efficacy of oral irinotecan against neuroblastoma xenografts. Anticancer Drugs (1997) 0.90
Chemotherapy of childhood rhabdomyosarcomas growing as xenografts in immune-deprived mice. Cancer Res (1982) 0.90
Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts. Cancer Chemother Pharmacol (2000) 0.89
Bioactive chemical constituents from Alchornea laxiflora (benth) pax and hoffman. J Ethnopharmacol (2001) 0.89
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models. Invest New Drugs (1996) 0.89
Fibroblast growth stimulation by extracts and compounds of Onosma argentatum roots. J Ethnopharmacol (2005) 0.89
The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans. Phytother Res (2006) 0.88
Resistance to rapamycin: a novel anticancer drug. Cancer Metastasis Rev (2001) 0.88
Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor. Cell Growth Differ (1996) 0.88
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts. Clin Cancer Res (1998) 0.88
A survey from the literature of plants used to treat scorpion stings. J Ethnopharmacol (1998) 0.88
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines. Cancer Chemother Pharmacol (1999) 0.88
Cell cycle control processes determine cytostasis or cytotoxicity in thymineless death of colon cancer cells. Cancer Res (1994) 0.87
Ethnobotanical survey and cytotoxicity testing of plants of South-western Nigeria used to treat cancer, with isolation of cytotoxic constituents from Cajanus cajan Millsp. leaves. J Ethnopharmacol (2010) 0.87
On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice. Cancer (1980) 0.87
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma. Clin Cancer Res (1998) 0.86
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors. Cancer Chemother Pharmacol (1999) 0.86
Areca nut, energy metabolism and hunger in Asian men. Ann Hum Biol (2003) 0.86
The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study. Phytother Res (2007) 0.86
Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas. Biochem Pharmacol (1986) 0.86
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan. Clin Cancer Res (2000) 0.85
Characteristics of thymidylate synthase purified from a human colon adenocarcinoma. Arch Biochem Biophys (1988) 0.85
Antioxidant and antimicrobial activities of Onosma argentatum and Rubia peregrina. Fitoterapia (2003) 0.85
Antimicrobial activities of a new schizozygane indoline alkaloid from Schizozygia coffaeoides and the revised structure of isoschizogaline. J Nat Prod (2002) 0.85
Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice. Cancer Chemother Pharmacol (2001) 0.85
Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Baill., Securinega virosa Roxb. &Wlld. and Microglossa pyrifolia Lam. Phytother Res (2006) 0.85
A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma. Clin Cancer Res (1998) 0.84
Toxicity studies of Tithonia diversifolia A. Gray (Asteraceae) in rats. J Ethnopharmacol (2008) 0.84